Youmna Ghaleb

704 total citations
11 papers, 191 citations indexed

About

Youmna Ghaleb is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Youmna Ghaleb has authored 11 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Youmna Ghaleb's work include Lipoproteins and Cardiovascular Health (11 papers), Lipid metabolism and disorders (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Youmna Ghaleb is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Lipid metabolism and disorders (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Youmna Ghaleb collaborates with scholars based in Lebanon, France and Canada. Youmna Ghaleb's co-authors include Cathérine Boileau, Marianne Abifadel, Sandy Elbitar, Mathilde Varret, Petra El Khoury, Jean‐Pierre Rabès, Melody Chemaly, Nabil G. Seidah, Éric Bruckert and Valérie Carreau and has published in prestigious journals such as Scientific Reports, Atherosclerosis and Diabetes Obesity and Metabolism.

In The Last Decade

Youmna Ghaleb

11 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youmna Ghaleb Lebanon 7 165 39 33 29 26 11 191
Sandy Elbitar Lebanon 7 165 1.0× 39 1.0× 33 1.0× 29 1.0× 29 1.1× 12 194
Merel L. Hartgers Netherlands 9 236 1.4× 39 1.0× 29 0.9× 55 1.9× 46 1.8× 19 268
Donald Moshen Tanyanyiwa South Africa 5 250 1.5× 46 1.2× 70 2.1× 42 1.4× 33 1.3× 12 327
Ryo Kawakami Japan 9 73 0.4× 34 0.9× 122 3.7× 28 1.0× 75 2.9× 21 275
Julius L. Katzmann Germany 11 220 1.3× 74 1.9× 69 2.1× 48 1.7× 86 3.3× 31 345
Vincenza Valenti Italy 10 195 1.2× 134 3.4× 65 2.0× 90 3.1× 174 6.7× 12 360
Rebecca F. Goldfaden United States 6 75 0.5× 39 1.0× 35 1.1× 13 0.4× 16 0.6× 16 125
Ana Margarida Medeiros Portugal 10 333 2.0× 89 2.3× 45 1.4× 109 3.8× 70 2.7× 27 403
Lukáš Tichý Czechia 10 211 1.3× 72 1.8× 56 1.7× 87 3.0× 50 1.9× 26 289
Melinde Wijers Netherlands 6 101 0.6× 26 0.7× 95 2.9× 35 1.2× 25 1.0× 7 256

Countries citing papers authored by Youmna Ghaleb

Since Specialization
Citations

This map shows the geographic impact of Youmna Ghaleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youmna Ghaleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youmna Ghaleb more than expected).

Fields of papers citing papers by Youmna Ghaleb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youmna Ghaleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youmna Ghaleb. The network helps show where Youmna Ghaleb may publish in the future.

Co-authorship network of co-authors of Youmna Ghaleb

This figure shows the co-authorship network connecting the top 25 collaborators of Youmna Ghaleb. A scholar is included among the top collaborators of Youmna Ghaleb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youmna Ghaleb. Youmna Ghaleb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ghaleb, Youmna, Sandy Elbitar, S Jambart, et al.. (2022). Low circulating PCSK9 levels in LPL homozygous children with chylomicronemia syndrome in a syrian refugee family in Lebanon. Frontiers in Genetics. 13. 961028–961028. 1 indexed citations
2.
Gannagé‐Yared, Marie‐Hélène, Sandy Elbitar, Youmna Ghaleb, et al.. (2022). Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren. Metabolites. 12(6). 504–504. 1 indexed citations
3.
Ghaleb, Youmna, Sandy Elbitar, Georges Halaby, et al.. (2021). Identification of a Variant in APOB Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese Families. Metabolites. 11(9). 564–564. 3 indexed citations
4.
Elbitar, Sandy, Delia Susan‐Resiga, Youmna Ghaleb, et al.. (2018). New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia. Scientific Reports. 8(1). 1943–1943. 25 indexed citations
5.
Khoury, Petra El, Philippe Couvert, Sandy Elbitar, et al.. (2018). Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1. Journal of clinical lipidology. 12(6). 1374–1382. 10 indexed citations
6.
Ghaleb, Youmna, Sandy Elbitar, Petra El Khoury, et al.. (2018). Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?. European Journal of Human Genetics. 26(4). 570–578. 18 indexed citations
7.
Khoury, Petra El, Sandy Elbitar, Youmna Ghaleb, et al.. (2017). PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies. Current Atherosclerosis Reports. 19(12). 49–49. 22 indexed citations
8.
Khoury, Petra El, Ronan Roussel, Frédéric Fumeron, et al.. (2017). Plasma proprotein‐convertase‐subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes. Diabetes Obesity and Metabolism. 20(4). 943–953. 14 indexed citations
9.
Khoury, Petra El, Ronan Roussel, Frédéric Fumeron, et al.. (2017). Plasma PCSK9 and cardiovascular events in type 2 diabetes. Atherosclerosis. 263. e81–e81. 1 indexed citations
10.
Elbitar, Sandy, Petra El Khoury, Youmna Ghaleb, et al.. (2016). Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015). Expert Opinion on Therapeutic Patents. 26(12). 1377–1392. 20 indexed citations
11.
Abifadel, Marianne, Sandy Elbitar, Petra El Khoury, et al.. (2014). Living the PCSK9 Adventure: from the Identification of a New Gene in Familial Hypercholesterolemia Towards a Potential New Class of Anticholesterol Drugs. Current Atherosclerosis Reports. 16(9). 439–439. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandy Elbitar Breakdown of academic impact, for papers by Merel L. Hartgers Breakdown of academic impact, for papers by Donald Moshen Tanyanyiwa Breakdown of academic impact, for papers by Ryo Kawakami Breakdown of academic impact, for papers by Julius L. Katzmann Breakdown of academic impact, for papers by Vincenza Valenti Breakdown of academic impact, for papers by Rebecca F. Goldfaden Breakdown of academic impact, for papers by Ana Margarida Medeiros Breakdown of academic impact, for papers by Lukáš Tichý Breakdown of academic impact, for papers by Melinde Wijers
Rankless by CCL
2026